How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web â from the tiniest of life forms to apex predators â alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
InnehÄll tillhandahÄllet av Jon Chee. Allt poddinnehÄll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahÄlls direkt av Jon Chee eller deras podcastplattformspartner. Om du tror att nÄgon anvÀnder ditt upphovsrÀttsskyddade verk utan din tillÄtelse kan du följa processen som beskrivs hÀr https://sv.player.fm/legal.
Player FM - Podcast-app
GĂ„ offline med appen Player FM !
GĂ„ offline med appen Player FM !
𧏠David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups
MP3•Episod hem
Manage episode 426981165 series 3461709
InnehÄll tillhandahÄllet av Jon Chee. Allt poddinnehÄll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahÄlls direkt av Jon Chee eller deras podcastplattformspartner. Om du tror att nÄgon anvÀnder ditt upphovsrÀttsskyddade verk utan din tillÄtelse kan du följa processen som beskrivs hÀr https://sv.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code âTBSPâ on https://www.excedr.com/rewards.
Part 2 of 4.
My guest for this weekâs episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.
David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Davidâs pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
- The challenges of moving from private equity to startups
- Aligning personal values with career choices, building solid teams, and the role of luck in success.
- His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer
Please enjoy my conversation with David Li.
Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and canât control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Goldman Sachs https://www.goldmansachs.com/
Benchling https://www.benchling.com/
Everest Detection https://everestdetection.com/
Salesforce https://www.salesforce.com/
Digitization of Life Sciences https://www.deloitte.com/global/en/Industries/life-sciences-health-care/perspectives/gx-digital-transformation-in-life-sciences.html
Go-to-Market Motion/Strategy https://www.wrike.com/go-to-market-guide/faq/what-is-go-to-market-motion/
Marketing & Sales Strategies & Tools https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Structuring Sales Comp at a Startup https://www.vouris.com/blog/sales-compensation-plan-for-startups
Content Marketing https://mailchimp.com/marketing-glossary/content-marketing/
Product Marketing vs. Growth Marketing https://userpilot.com/blog/product-marketing-vs-growth-marketing/
People Mentioned:
Bryan Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 episoder
MP3•Episod hem
Manage episode 426981165 series 3461709
InnehÄll tillhandahÄllet av Jon Chee. Allt poddinnehÄll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahÄlls direkt av Jon Chee eller deras podcastplattformspartner. Om du tror att nÄgon anvÀnder ditt upphovsrÀttsskyddade verk utan din tillÄtelse kan du följa processen som beskrivs hÀr https://sv.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code âTBSPâ on https://www.excedr.com/rewards.
Part 2 of 4.
My guest for this weekâs episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.
David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Davidâs pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
- The challenges of moving from private equity to startups
- Aligning personal values with career choices, building solid teams, and the role of luck in success.
- His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer
Please enjoy my conversation with David Li.
Timestamps:
00:28 Intro
01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact
04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics
06:25 Experience at Benchling, data software issues & digitization in the life sciences
11:09 The role of luck in success, figuring out what you can and canât control
14:02 Challenges and lessons working in startups, maintaining internal conviction
17:43 Contemplating a new role after Benchling, joining Everest Detection
20:25 The different skills David learned while building a team, getting wins early on
23:56 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Goldman Sachs https://www.goldmansachs.com/
Benchling https://www.benchling.com/
Everest Detection https://everestdetection.com/
Salesforce https://www.salesforce.com/
Digitization of Life Sciences https://www.deloitte.com/global/en/Industries/life-sciences-health-care/perspectives/gx-digital-transformation-in-life-sciences.html
Go-to-Market Motion/Strategy https://www.wrike.com/go-to-market-guide/faq/what-is-go-to-market-motion/
Marketing & Sales Strategies & Tools https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Structuring Sales Comp at a Startup https://www.vouris.com/blog/sales-compensation-plan-for-startups
Content Marketing https://mailchimp.com/marketing-glossary/content-marketing/
Product Marketing vs. Growth Marketing https://userpilot.com/blog/product-marketing-vs-growth-marketing/
People Mentioned:
Bryan Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 episoder
Alle afleveringen
×VĂ€lkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den Àr den bÀsta podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.